Manimaran, D., Elangovan, N. and Palanisamy, V. 2024. Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type. Jordan Journal of Pharmaceutical Sciences. 17, 4 (Dec. 2024), 783–793. DOI:https://doi.org/10.35516/jjps.v17i4.2482.